Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.
JNCCN Journal of the National Comprehensive Cancer Network.
Times cited: 13
Open-label study of oral CEP-701 (lestaurtinib) in patients with polycythaemia vera or essential thrombocythaemia with JAK2-V617F mutation.
British Journal of Haematology.
Times cited: 16
Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms.
Times cited: 29